Elena Tsourdi

Elena studied medicine in Athens, Greece and finished her residency in Endocrinology at the University Clinic Dresden (TUD). She obtained her MD degree at the TUD in 2011 in the bone field. Currently she is working as the Senior Consultant at the Department for Metabolic Bone Diseases, with a focus on secondary osteoporosis and rare bone diseases. She actively participates as co-investigator in several clinical phase 2/3 studies including studies to investigate the safety and efficacy of romosozumab for the treatment of osteoporosis, the efficacy of bimagrumab to prevent sarcopenia and the use of recombinant human parathyroid hormone in the treatment of primary hypoparathyroidism.